N-Myristoyltransferase from Leishmania donovani: Structural and Functional Characterisation of a Potential Drug Target for Visceral Leishmaniasis
Open Access
- 5 March 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Molecular Biology
- Vol. 396 (4), 985-999
- https://doi.org/10.1016/j.jmb.2009.12.032
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust (066742, 077503, 087792)
- David Phillips Research Fellowship (BB/D02014X/1)
This publication has 54 references indexed in Scilit:
- Myristoyl-CoA:protein N-myristoyltransferase depletion in trypanosomes causes avirulence and endocytic defectsMolecular and Biochemical Parasitology, 2009
- CHAINSAW: a program for mutating pdb files used as templates in molecular replacementJournal of Applied Crystallography, 2008
- Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparumBiochemical Journal, 2007
- Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasisVaccine, 2007
- Comparative genomic analysis of three Leishmania species that cause diverse human diseaseNature Genetics, 2007
- Kinetoplastid PPEF phosphatases: Dual acylated proteins expressed in the endomembrane system of LeishmaniaMolecular and Biochemical Parasitology, 2007
- Protein production by auto-induction in high-density shaking culturesProtein Expression and Purification, 2005
- Developments in theCCP4 molecular-graphics projectActa Crystallographica Section D-Biological Crystallography, 2004
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D-Biological Crystallography, 2004
- ESPript: analysis of multiple sequence alignments in PostScript.Bioinformatics, 1999